Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

QCR Holdings Q1 Profit Rises

QCR Holdings Inc. (QCRH: Quote) posted first-quarter net income attributable to common stockholders of $2.3 million or $0.48 per share, compared to $1.1 million or $0.23 per share last year.

Net income attributable to the company was $3.2 million, up from $2.1 million in the previous year quarter.

The company's net interest income for the current quarter rose to $14.2 million from $12.2 million in the comparable quarter last year, while non-interest income was $3.96 million, compared to $5.06 million in the same quarter last year.

Click here to receive FREE breaking news email alerts for QCR Holdings Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
The Reserve Bank of India kept its key rates unchanged once again as expected, citing upside risks to medium-term inflation target. The decision announced Tuesday meant that the repo rate was left unchanged at 8.00 percent for the fourth straight policy meeting. The repo rate is the rate at which the central bank lends to commercial banks. The Reserve Bank of India kept its key rates unchanged once again as expected, citing upside risks to medium-term inflation target. The decision announced Tuesday meant that the repo rate was left unchanged at 8.00 percent for the fourth straight policy meeting. The repo rate is the rate at which the central bank lends to commercial banks. U.K. house prices unexpectedly declined in September after rising for sixteen straight months amid signs that demand may be starting to ease, the results of a survey by the Nationwide Building Society showed Tuesday. The house price index dropped 0.2 percent from August, when it climbed 0.8 percent....
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.